Caribou Biosciences

Caribou Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing next-generation, genome-edited cell therapies using its innovative CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA). The company is committed to transforming the lives of patients with devastating diseases by leveraging its expertise in the development of patented CRISPR technology. Caribou Biosciences is dedicated to advancing precision medicine by creating safe and effective cell therapies that can treat a range of diseases such as cancer, genetic disorders, and infectious diseases. With a strong focus on research and development, Caribou Biosciences is poised to revolutionize the field of gene editing and improve patient outcomes.